Smart Health Innovation Lab, a market adoption accelerator for healthcare technologies, today announced the graduation of two companies — Emovi and NeuroFlow – from its Smart Health Certification Program’s inaugural class of 2018. Read more >>
Corbus Pharmaceuticals Holdings, Inc.(NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious…
read moreJoe Marques, who is legally blind, received the gift of sight this year thanks to the generous donations from…
read moreMyomo, a medical robotics company, has submitted a Form 1-A with the Securities and Exchange Commission regarding its proposes…
read moreIt has been one week since Myomo (NYSE:MYO) became the first Reg A+ issuer to successfully crowdfund and then…
read moreSiamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the presentation of new preclinical data for…
read morePlatelet BioGenesis, the leader in the production of functional human platelets (PLTs+TM) from stem cells and the development of…
read more“It’s the way many millennial parents shop now. We want to access the expensive products without having to spend…
read moreCarbonite, Inc., a leader in cloud-based data protection, will showcase the Carbonite Data Protection Platform at Dell Technologies World,…
read moreThe following post is from Antonette Ho, Group Operations Manager at Boston Harbor Angels.
Corbus Pharmaceuticals Wins Exit of the…
Myomo, a wearable medical robotics company, announced that MyoPro — its myoelectric orthosis or powered brace — is now…
read more